TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

Autor: Alison E. Cowper, Xiao-Ning Xu, Gavin R. Screaton, Andrew J. McMichael, Juthathip Mongkolsapaya, John I. Bell
Rok vydání: 1997
Předmět:
Programmed cell death
Molecular Sequence Data
Apoptosis
Biology
Jurkat cells
General Biochemistry
Genetics and Molecular Biology

Fas ligand
Receptors
Tumor Necrosis Factor

TNF-Related Apoptosis-Inducing Ligand
03 medical and health sciences
0302 clinical medicine
Cytotoxic T cell
Animals
Amino Acid Sequence
Cloning
Molecular

Receptor
030304 developmental biology
Death domain
0303 health sciences
Binding Sites
Membrane Glycoproteins
Agricultural and Biological Sciences(all)
Tumor Necrosis Factor-alpha
Biochemistry
Genetics and Molecular Biology(all)

Fas receptor
Molecular biology
Cell biology
Alternative Splicing
Receptors
TNF-Related Apoptosis-Inducing Ligand

Cell killing
030220 oncology & carcinogenesis
COS Cells
General Agricultural and Biological Sciences
Apoptosis Regulatory Proteins
Signal Transduction
Zdroj: Current Biology. 7(9):693-696
ISSN: 0960-9822
DOI: 10.1016/s0960-9822(06)00297-1
Popis: A subset of the tumour necrosis factor (TNF) receptor family contain a conserved intracellular motif, the death domain. Engagement of these receptors by their respective ligands initiates a signalling cascade that rapidly leads to cell death by apoptosis. We have cloned a new member of this family, TRICK2, the TRAIL (TNF-related apoptosis-inducing ligand) receptor inducer of cell killing 2. TRICK2 is expressed in a number of cell types, and to particularly high levels in lymphocytes and spleen. Two isoforms of the TRICK2 mRNA are generated by alternative pre-mRNA splicing and differ by a 29 amino-acid extension to the extracellular domain. Overexpression of TRICK2 rapidly induced apoptosis in 293T cells; this induction was dependent upon the presence of the death domain of TRICK2. Using a soluble molecule containing the TRICK2 extracellular domain, we demonstrated that TRICK2, like DR4 [1], is a receptor for TRAIL/APO-2L [2,3] and could inhibit TRAIL-induced killing of lymphocyte lines, such as the Jurkat T-cell line. TRAIL is upregulated upon lymphocyte activation, as is the intensively studied ligand for Fas, FasL [4]. TRAIL and its receptors might therefore provide another system for the regulation of lymphocyte selection and proliferation, as well as providing an additional weapon in the armoury of cytotoxic lymphocytes.
Databáze: OpenAIRE